Onofri A, Pensato U, Rosignoli C, et al. Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis. J Headache Pain. 2023;24(1):8. https://doi.org/10.1186/s10194-023-01541-0.

Article  PubMed  PubMed Central  Google Scholar 

Nieswand V, Richter M, Gossrau G. Epidemiology of headache in children and adolescents-another type of pandemia. Curr Pain Headache Rep. 2020;24(10):62. https://doi.org/10.1007/s11916-020-00892-6.

Article  PubMed  PubMed Central  Google Scholar 

Lateef TM, Merikangas KR, He J, et al. Headache in a national sample of American children: prevalence and comorbidity. J Child Neurol. 2009;24(5):536–43. https://doi.org/10.1177/0883073808327831.

Article  PubMed  PubMed Central  Google Scholar 

Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52(12):1088–97. https://doi.org/10.1111/j.1469-8749.2010.03793.x.

Article  PubMed  Google Scholar 

Yang Y, Cao Y. Rising trends in the burden of migraine and tension-type headache among adolescents and young adults globally, 1990 to 2019. J Headache Pain. 2023;24(1):94. https://doi.org/10.1186/s10194-023-01634-w.

Article  PubMed  PubMed Central  Google Scholar 

Orr SL, Kabbouche MA, O’Brien HL, Kacperski J, Powers SW, Hershey AD. Paediatric migraine: evidence-based management and future directions. Nat Rev Neurol. 2018;14(9):515–27. https://doi.org/10.1038/s41582-018-0042-7.

Article  CAS  PubMed  Google Scholar 

Leung S, Bulloch B, Young C, et al. Effectiveness of standardized combination therapy for migraine treatment in the pediatric emergency department. Headache. 2013;53(3):171–7. https://doi.org/10.1111/head.12042.

Article  Google Scholar 

Falla K, Kuziek J, Mahnaz SR, Noel M, Ronksley PE, Orr SL. Anxiety and depressive symptoms and disorders in children and adolescents with migraine: a systematic review and meta-analysis. JAMA Pediatr. 2022;176(12):1176–87. https://doi.org/10.1001/jamapediatrics.2022.3940.

Article  PubMed  PubMed Central  Google Scholar 

Powers SW, Coffey CS, Chamberlin LA, et al. Prevalence of headache days and disability 3 years after participation in the childhood and adolescent migraine prevention medication trial. JAMA Netw Open. 2021;4(7):1–14. https://doi.org/10.1001/jamanetworkopen.2021.14712.

Article  Google Scholar 

Canfora M, Pallotto IK, Davis JK, et al. More than a headache: lived experience of migraine in youth. Pediatr Neurol. 2023;146:79–84. https://doi.org/10.1016/j.pediatrneurol.2023.05.019.

Article  PubMed  Google Scholar 

Abu-Arafeh I. Headache and psychological comorbidities: an appraisal of the evidence. J Clin Med. 2023;12(7). https://doi.org/10.3390/jcm12072683.

Brainstorm Consortium, Anttila V, Bulik-Sullivan B, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018;360(6395):eaap8757. https://doi.org/10.1126/science.aap8757.

Article  CAS  Google Scholar 

Stovner LJ, Nichols E, Steiner TJ, et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954–76. https://doi.org/10.1016/S1474-4422(18)30322-3.

Article  Google Scholar 

Wöber-Bingöl C. Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep. 2013;17(6):341. https://doi.org/10.1007/s11916-013-0341-z.

Article  PubMed  Google Scholar 

Perry MC, Yaeger SK, Toto RL, Suresh S, Hickey RW. A modern epidemic: increasing pediatric emergency department visits and admissions for headache. Pediatr Neurol. 2018;89:19–25. https://doi.org/10.1016/j.pediatrneurol.2018.07.015.

Article  PubMed  PubMed Central  Google Scholar 

Gelfand AA, Goadsby PJ. Treatment of pediatric migraine in the emergency room. Pediatr Neurol. 2012;47(4):233–41. https://doi.org/10.1016/j.pediatrneurol.2012.06.001.

Article  PubMed  PubMed Central  Google Scholar 

Raucci U, Della Vecchia N, Ossella C, et al. Management of childhood headache in the emergency department. Review of the literature. Front Neurol. 2019;10:886. https://doi.org/10.3389/fneur.2019.00886. Published 2019 Aug 23.

Article  PubMed  PubMed Central  Google Scholar 

Dooley JM, Augustine HF, Brna PM, Digby AM. The prognosis of pediatric headaches - A 30-year follow-up study. Pediatr Neurol. 2014;51(1):85–7. https://doi.org/10.1016/j.pediatrneurol.2014.02.022.

Article  PubMed  Google Scholar 

Galinski M, Sidhoum S, Cimerman P, Perrin O, Annequin D, Tourniaire B. Early diagnosis of migraine necessary in children: 10-year follow-up. Pediatr Neurol. 2015;53(4):319–23. https://doi.org/10.1016/j.pediatrneurol.2015.05.013.

Article  PubMed  Google Scholar 

Orr SL, Shapiro RE. The elephant in the room: How the underfunding of headache research stunts the field. Headache. 2022;62(9):1234–8. https://doi.org/10.1111/head.14396.

Article  PubMed  Google Scholar 

Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine. Drugs. 2000;60(6):1259–87. https://doi.org/10.2165/00003495-200060060-00003.

Article  CAS  PubMed  Google Scholar 

Humphrey PPA. The discovery and development of the triptans, a major therapeutic breakthrough. Headache. 2008;48(5):685–7. https://doi.org/10.1111/J.1526-4610.2008.01097.X.

Article  PubMed  Google Scholar 

Ahn AH, Basbaum AI. Where do triptans act in the treatment of migraine? Pain. 2005;115(1–2):1–4. https://doi.org/10.1016/j.pain.2005.03.008.

Article  PubMed  PubMed Central  Google Scholar 

Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33(1):48–56. https://doi.org/10.1002/ana.410330109.

Article  CAS  PubMed  Google Scholar 

Juhasz G, Zsombok T, Jakab B, Nemeth J, Szolcsanyi J, Bagdy G. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia. 2005;25(3):179–83. https://doi.org/10.1111/J.1468-2982.2005.00836.X.

Article  CAS  PubMed  Google Scholar 

Puledda F, Silva EM, Suwanlaong K, Goadsby PJ. Migraine: from pathophysiology to treatment. J Neurol. 2023;270(7):3654–66. https://doi.org/10.1007/s00415-023-11706-1.

Article  PubMed  PubMed Central  Google Scholar 

Vila-Pueyo M. Targeted 5-HT1F therapies for migraine. Neurotherapeutics. 2018;15(2):291–303. https://doi.org/10.1007/S13311-018-0615-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goadsby PJ, Akerman S, Storer RJ. Evidence for postjunctional serotonin (5-HT1) receptors in the trigeminocervical complex. Ann Neurol. 2001;50(6):804–7. https://doi.org/10.1002/ana.10066.

Article  CAS  PubMed  Google Scholar 

Wiggers A, Ashina H, Hadjikhani N, et al. Brain barriers and their potential role in migraine pathophysiology. J Headache Pain. 2022;23(1):1–10. https://doi.org/10.1186/s10194-021-01365-w.

Article  Google Scholar 

Pleș H, Florian IA, Timis TL, et al. Migraine: advances in the pathogenesis and treatment. Neurol Int. 2023;15(3):1052–105. https://doi.org/10.3390/neurolint15030067.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Humphrey PPA, Feniuk W, Perren MJ, Connor HE, Oxford AW. The pharmacology of the novel 5-HT1-like receptor agonist, GR43175. Cephalalgia. 1989;9(SUPPL. 9):23–33. https://doi.org/10.1111/J.1468-2982.1989.TB00069.X.

Article  PubMed  Google Scholar 

Humphrey PPA. 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol. 1991;238(1 Supplement). https://doi.org/10.1007/BF01642905.

Humphrey PP, Feniuk W, Perren MJ, et al. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol. 1988;94(4):1123–32. https://doi.org/10.1111/j.1476-5381.1988.tb11630.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pini LA, Brovia D. Different characteristics of triptans. J Headache Pain. 2004;5(SUPPL. 2). https://doi.org/10.1007/s10194-004-0122-5.

•• Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019;93:487–99. https://doi.org/10.1212/WNL.0000000000008095. Updated guidelines on acute care, thoughtful systematic review, and endorsed by the American Academy of Pediatrics and Child Neurology Society.

Endorsement SOF. Acute treatment of migraine in children and adolescents. Pediatrics. 2019;144(5):20192762. https://doi.org/10.1542/peds.2019-2762.

Article  Google Scholar 

Practice guideline update: acute treatment of migraine in children and adolescents. https://www.aan.com/Guidelines/home/GuidelineDetail/966. Accessed 30 Jan 2024.

Olesen J. Headache Classification Committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202.

Article  Google Scholar 

Dodick D, Lipton RB, Martin V, et al. Consensus statement: Cardiovascular safety profile of triptans (5-HT 1B/1D agonists) in the acute treatment of migraine. Headache. 2004;44(5):414–25. https://doi.org/10.1111/j.1526-4610.2004.04078.x.

Article  PubMed